{"id":"W3135647768","doi":"10.1038/s41375-021-01179-4","title":"Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Novartis; U.S. Department of Health and Human Services","keywords":"Midostaurin; Medicine; Internal medicine; Cytarabine; Oncology; Cumulative incidence; Myeloid leukemia; Preleukemia; Maintenance therapy; Transplantation; Surgery; Leukemia; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001108938,0.0009521396,0.001788022,0.000253739,0.0003623133,0.001279994,0.0008346543,0.0008735258,0.004120837],"category_scores_gemma":[0.001220234,0.000228087,0.001621338,0.0003674302,0.0006274075,0.0009179159,0.0006020507,0.003714417,0.0008329719],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001653789,"about_ca_system_score_gemma":0.001080783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002064847,"about_ca_topic_score_gemma":0.008921728,"domain_scores_codex":[0.9995665,0.0001685327,0.00001997187,0.00006186245,0.00006630412,0.000116771],"domain_scores_gemma":[0.9994942,0.00008006367,0.0001271507,0.0000567868,0.00003749855,0.0002042796],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6341532,0.004543736,0.009629066,0.001625489,0.005953606,0.0002177027,0.0001839596,0.003908904,0.01215468,0.004122643,0.05424073,0.2692662],"study_design_scores_gemma":[0.7785112,0.08793972,0.07226492,0.0005989253,0.005499347,0.0005941951,0.0003956204,0.003582676,0.003211291,0.007407004,0.03983763,0.0001575836],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9548603,0.01911765,0.0006466025,0.006901568,0.001167059,0.0004541796,0.00273098,0.0003367195,0.01378496],"genre_scores_gemma":[0.9765053,0.006372087,0.0009193069,0.004195279,0.0006194073,0.0004427224,0.004255129,0.00008384966,0.006606879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004120837,"threshold_uncertainty_score":0.01378554,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02581105720882084,"score_gpt":0.3097408282084322,"score_spread":0.2839297709996114,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}